Ross Haghighat

Ross Haghighat is a seasoned executive with extensive experience in leadership roles across multiple industries. Currently serving as Chairman and CEO of Triton Systems, Inc. since May 1992, Ross has been instrumental in launching innovative products and solutions in emerging markets. As Executive Chairman of Avertix Medical since March 2019, Ross oversees the development of the first FDA-approved Class III implantable device for detecting silent heart attacks. Additionally, Ross contributes to the governance of several companies as a member of the Board of Directors for Chinook Therapeutics, Electriq Global, and Fluence Corporation, as well as holding the position of Chairman of the Board at FRX Polymers, Inc. Ross holds both a BS and MS in Advanced Materials from Rutgers University and an MBA from Boston College Carroll School of Management.